These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 25984709

  • 1. Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project.
    Laoutidis ZG, Konstantinidis A, Grohmann R, Luckhaus C, Mobascher J, Cordes J.
    Pharmacopsychiatry; 2015 Jul; 48(4-5):178-81. PubMed ID: 25984709
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amisulpride-induced neuroleptic malignant syndrome.
    Abay E, Kose R.
    J Neuropsychiatry Clin Neurosci; 2007 Jul; 19(4):488-9. PubMed ID: 18070872
    [No Abstract] [Full Text] [Related]

  • 4. Serum creatine kinase elevation associated with olanzapine treatment.
    Punukollu B, Rutherford H.
    BMJ Case Rep; 2008 Jul; 2008():bcr0620080040. PubMed ID: 21716813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Marked elevation of serum creatine kinase associated with olanzapine therapy.
    Marcus EL, Vass A, Zislin J.
    Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Massive creatine kinase elevations with quetiapine: report of two cases.
    Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC.
    Pharmacopsychiatry; 2006 Jan; 39(1):39-40. PubMed ID: 16453254
    [Abstract] [Full Text] [Related]

  • 10. Amisulpride and neuroleptic malignant syndrome.
    Tu MC, Hsiao CC.
    Chang Gung Med J; 2011 Jan; 34(5):536-40. PubMed ID: 22035899
    [Abstract] [Full Text] [Related]

  • 11. [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
    Pedrosa Gil F, Schneider C, Grohmann R, Rüther E.
    Nervenarzt; 2001 Sep; 72(9):729-33. PubMed ID: 11572107
    [Abstract] [Full Text] [Related]

  • 12. Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.
    Holtmann M, Meyer AE, Pitzer M, Schmidt MH.
    Pharmacopsychiatry; 2003 Nov; 36(6):317-8. PubMed ID: 14663658
    [Abstract] [Full Text] [Related]

  • 13. The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.
    O'Dwyer AM, Sheppard NP.
    Psychol Med; 1993 May; 23(2):323-6. PubMed ID: 8101383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):92-6. PubMed ID: 16938372
    [Abstract] [Full Text] [Related]

  • 18. [Amisulpride--a neuroleptic agent for all phases of schizophrenia].
    Nervenarzt; 1999 Mar 30; 70(3 Suppl Amisulprid):1-8. PubMed ID: 10221135
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M, El Ghazouani F, Zaimi O, Oneib B.
    Presse Med; 2018 Feb 30; 47(2):172-174. PubMed ID: 29395559
    [No Abstract] [Full Text] [Related]

  • 20. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A, Cazali J.
    J Clin Psychopharmacol; 2007 Oct 30; 27(5):514-6. PubMed ID: 17873688
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.